Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology

REFERENCES

• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618-628; PMID:22710755; https://doi.org/10.1016/S1474-4422(12)70063-7
   PubMed Web of Science ®Google Scholar
• Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P. Updatec clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132:2659-2668; PMID:19773352; https://doi.org/10.1093/brain/awp191
   PubMed Web of Science ®Google Scholar
• Henkel K, Zerr I, Hertel A, Gratz KF, Schröter A, Tschampa HJ, Bihl H, Büll U, Grünwald F, Drzezga A, Spitz J, Poser S. Positron emission tomography with [18F]FDG in the diagnosis of Creutzelft-Jakob disease (CJD). J Neurol 2002; 249:699-705; PMID:12111302; https://doi.org/10.1007/s00415-002-0695-3
   PubMed Web of Science ®Google Scholar
• Kim EJ, Cho SS, Jeong BH, Kim YS, Seo SW, Na DL, Geschwind MD, Jeong Y. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: an SPM analysis of 18F-FDG PET. Eur J Neurol 2012; 19:488-493; PMID:22050286; https://doi.org/10.1111/j.1468-1331.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Renard D, Vandenbergue R, Collombier L, Kotzki PO, Pouget JP, Boudousq V. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis. J Neurol 2013; 260:3055-3064; PMID:24068371; https://doi.org/10.1007/s00415-013-7117-6
   PubMed Web of Science ®Google Scholar
• Prieto E, Domínguez-Prado I, Riverol M, Ortega-Cubero S, Ribelles MJ, Luquin MR, de Castro P, Arbizu J. Metabolic patterns in prion diseases: an FDG PET voxel-based analysis. Eur J Nucl Med Mol Imaging 2015; 42:1522-1529; PMID:26041084; https://doi.org/10.1007/s00259-015-3090-x
   PubMed Web of Science ®Google Scholar
• Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra UP. The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literatura. J Neuroimaging 2015; 25:2-13; PMID:24593302; https://doi.org/10.1111/jon.12098
   PubMed Web of Science ®Google Scholar
• Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, Jones G, Baxendale D, Masters CL, Rowe CC, Collins SJ. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2009; 80:998-1001; PMID:19332421; https://doi.org/10.1136/jnnp.2008.171496
   PubMed Web of Science ®Google Scholar
• Okamura N, Shiga Y, Furumoto S, Tashiro M, Tsuboi Y, Furukawa K, Yanai K, Iwata R, Arai H, Kudo Y, Itovama Y, Doh-ura K. In vivo detection of prion amyloid plaques using [11C]BF-227 PET. Eur J Nucl Med Mol Imaging 2010; 37:934-941; PMID:20016895; https://doi.org/10.1007/s00259-009-1314-7
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Doh-ura K, Kudo Y, Nishida N, Murakami-Kubo I, Ando Y, Sawada T, Iwaki T. Amyloid imaging probes are useful for detection of prion plaques and treatment of transmisible spongiform encephalopaties. J Gen Virol 2004; 85:1785-1790; PMID:15166464; https://doi.org/10.1099/vir.0.19754-0
   PubMed Web of Science ®Google Scholar
• Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O, for the Florbetaben Study Group. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic group. Lancet Neurol 2011; 10:424-435; PMID:21481640; https://doi.org/10.1016/S1474-4422(11)70077-1
   PubMed Web of Science ®Google Scholar
• Ashburner J, Friston KJ. Voxel-based morphometry–the methods. Neuroimage 2000;11:805-21; PMID:10860804; https://doi.org/10.1006/nimg.2000.0582
   PubMed Web of Science ®Google Scholar
• Tzourio-Mazoyer N, Landeau D, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15:273-89; PMID:11771995; https://doi.org/10.1006/nimg.2001.0978
   PubMed Web of Science ®Google Scholar
• Fändrich M, Schmidt M, Grigorieff N. Recent progress in understanding Alzheimer's β-amyloid structures. Trends Biochem Sci 2011; 36:338-345; PMID:21411326; https://doi.org/10.1016/j.tibs.2011.02.002
   PubMed Web of Science ®Google Scholar
• Hubin E, Deroo S, Schierle GK, Kaminski C, Serpell L, Subramaniam V, van Nuland N, Broersen K, Raussens V, Sarroukh R. two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes. Cell Mol Life Sci 2015; 72:4899-913; PMID:26190022; https://doi.org/10.1007/s00018-015-1983-2
   PubMed Web of Science ®Google Scholar
• Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'Neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology 2007; 69:283-290; PMID:17636066; https://doi.org/10.1212/01.wnl.0000265815.38958.b6
   PubMed Web of Science ®Google Scholar
• Kepe V, Ghetti B, Farlow MR, Bresjanac M, Miller K, Huang SC, Wong KP, Murrell JR, Piccardo P, Epperson F, Repovs G, Smid LM, Petric A, Siddarth P, Liu J, Satyamurthy N, Small GW, Barrio JR. PET of brain prion amyloid protein in Gerstmann-Sträussler-Sheinker disease. Brain Pathology 2010; 20:419-430; PMID:19725833; https://doi.org/10.1111/j.1750-3639.2009.00306.x
   PubMed Web of Science ®Google Scholar
• Hyare H, Ramlackhansingh A, Gelosa G, Edison P, Rudge P, Brandner S, Brooks DJ, Collinge J, Mead S. 11C-PiB does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2012; 83:340-341; PMID:21478204; https://doi.org/10.1136/jnnp.2010.233692
   PubMed Web of Science ®Google Scholar
• Matías-Guiu JA, Oreja-Guevara C, Cabrera-Martín MN, Moreno-Ramos T, Carreras JL, Matías-Guiu J. Amyloid proteins and their role in multiple sclerosis. Considerations in the use of amyloid-PET imaging. Front Neurol 2016; 7:53
   PubMed Web of Science ®Google Scholar
• Budka H. Neuropathology of prion diseases. Br Med Bull 2003; 66:121-130; PMID:14522854; https://doi.org/10.1093/bmb/66.1.121
   PubMed Web of Science ®Google Scholar
• Mente KP, O'Donnell JK, Jones SE, Cohen ML, Thompson NR, Bizzi A, Gambetti P, Safar JG, Appleby BS. Fluorodeoxyglucose positron emission tomography (FDG-PET) correlation of histopathology and MRI in prion disease. Alzheimer Dis Assoc Disord 2017; 31(1):1-7; PMID:28121634; https://doi.org/10.1097/WAD.0000000000000188
   PubMed Web of Science ®Google Scholar
• Matías-Guiu JA, Pytel V, Cabrera-Martín MN, Galán L, Valles-Salgado M, Guerrero A, Moreno-Ramos T, Matías-Guiu J, Carreras JL. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging 2016; 43:2050-2060; PMID:27262702; https://doi.org/10.1007/s00259-016-3434-1
   PubMed Web of Science ®Google Scholar
• Matías-Guiu JA, Cabrera-Martín MN, Matías-Guiu J, Oreja-Guevara C, Riola-Parada C, Moreno-Ramos T, Arrazola J, Carreras JL. Amyloid PET imaging in multiple sclerosis: an (18)F-Florbetaben study. BMC Neurol 2015; 15:243; PMID:26607782; https://doi.org/10.1186/s12883-015-0502-2
   PubMed Web of Science ®Google Scholar
• Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 2011; 10:424-435; PMID:21481640; https://doi.org/10.1016/S1474-4422(11)70077-1
   PubMed Web of Science ®Google Scholar
• Linding R., Schymkowitz J., Rousseau F., Diella F., Serrano L. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J. Mol. Biol 2004; 342:345-353; PMID:15313629; https://doi.org/10.1016/j.jmb.2004.06.088
   PubMed Web of Science ®Google Scholar
• Chiti F., Dobson C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem 2006: 75:333-366; PMID:16756495; https://doi.org/10.1146/annurev.biochem.75.101304.123901
   PubMed Web of Science ®Google Scholar
• Xing XW, Zhang JT, Zhu T, Ma L, Yin DY, Jia WQ, Huang XS, Pu CQ, Lang SY, Yu SY. Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucose-positron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease. J Clin Neurosci 2012; 19:1354-1357; PMID:22795494; https://doi.org/10.1016/j.jocn.2011.11.035
   PubMed Web of Science ®Google Scholar
• Ortega-Cubero S, Pagola I, Luquin MR, Viteri C, Pastor P, Gállego Pérez-Larraya J, de Castro P, Domínguez I, Irimia P, Martínez-Vila E, Arbizu J, Riverol M. Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study. Neurología 2015; 30:144-152; https://doi.org/10.1016/j.nrl.2013.12.004
   PubMed Web of Science ®Google Scholar
• Cistaro A, Cassalia L, Ferrara C, Atzori C, Vai D, Quartuccio N, Fania P, Vaudano GP, Imperiale D. Brain 18F-FDG PET/CT findings in a case of genetic Creutzfeldt-Jakob disease due to V203I heterozygous mutation in the PRNP gene. J Neurol 2017; 264:170-173; PMID:27844164; https://doi.org/10.1007/s00415-016-8327-5
   PubMed Web of Science ®Google Scholar